Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler

Journal of Biomedical Materials Research

Volumn 36, Issue 3, 1997, Pages 295-305

  Ongpipattanakul, Boonsri ^a   Nguyen, Tue ^a   Zioncheck, Thomas F ^a   Wong, Rita ^a   Osaka, Gary ^a   DeGuzman, Leo ^a   Lee, Wyne P ^a   Beck, L Steven ^a,b  

^a GENENTECH INC   (United States)

^b NONE   (United States)

Author keywords

Bone defect filler; In vivo efficacy; Pharmacokinetics; Release kinetics; Transforming growth factor 1

Indexed keywords

BONE; GAMMA RADIOGRAPHY; MECHANICAL TESTING; PHARMACOKINETICS; PHOSPHATE MINERALS; PHYSIOLOGICAL MODELS; PLASTIC ADHESIVES; RADIOACTIVITY;

AMYLOPECTIN; BONE DEFECT FILLERS; TRANSFORMING GROWTH FACTOR; TRICALCIUM PHOSPHATE;

BIOMATERIALS;

AMYLOPECTIN; BONE CEMENT; CALCIUM PHOSPHATE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MIXTURE; DRUG RELEASE; NONHUMAN; PASTE; RABBIT;

AMYLOPECTIN; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE CEMENTS; CALCIUM PHOSPHATES; FRACTURES, BONE; HUMANS; RABBITS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031554863     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19970905)36:3<295::AID-JBM4>3.0.CO;2-9     Document Type: Article

References (33)

1. R. Kenley, L. Marden, T. Turek, L. Jin, E. Ron, and J. O. Hollinger, "Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2)," J. Biomed. Mater. Res., 28, 1139-1147 (1994).
2. U. Ripamonti, S. Ma, N. S. Cunningham, L. Yeates, and A. H. Reddi, "Initiation of bone regeneration in adult baboons by osteogenin, a bone morphogenetic protein," Matrix, 12, 369-380 (1992).
3. S. M. Seyedin, T. C. Thomas, A. Y. Thompson, D. M. Rosen, and K. A. Piez, "Purification and characterization of two cartilage-inducing factors from bovine demineralized bone," Proc. Natl. Acad. Sci. USA, 82, 2267-2271 (1985).
4. E. A. Wang, V. Rosen, P. Cordes, R. M. Hewick, M. J. Kriz, D. P. Luxenberg, B. S. Sibley, and J. M. Rozney, "Purification and characterization of other distinct bone-inducing factors," Proc. Natl. Acad. Sci. USA, 85, 9484-9488 (1988).
5. D. J. Simmons, "Fracture healing," in Fundamental and Clinical Bone Physiology, M. R. Urist (ed.), J. B. Lippincott, Philadelphia, 1980, pp. 283-330.
6. M.E. Bolander, "Regulation of fracture repair by growth factors," Proc. Soc. Exp. Biol. Med., 200, 165-170 (1992).
7. I. A. Bab and T. A. Einhorn, "Polypeptide factors regulating osteogenesis and bone marrow repair," J. Cell. Biochem., 55, 358-365 (1994).
8. M. Centrella, T. L. McCarthy, and E. Canalis, "Transforming growth factor-beta and remodeling of bone," J. Bone Joint. Surg., 73-A, 1418-1428 (1991).
9. L. F. Bonewald and S. L. Dallas, "Role of active and latent transforming growth factor β in bone formation," J. Cell. Biochem., 55, 350-357 (1994).
10. M. Centrella, T. L. McCarthy, and E. Canalis, "Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bones," J. Biol. Chem., 262, 2869-2874 (1987).
11. M. Noda and J. J. Camilliere, "In vivo stimulation of bone formation by transforming growth factor β," Endocrinology, 124, 2291-2294 (1989).
12. L. S. Beck, L. Deguzman, W. P. Lee, Y. Xu, L. A. Mcfatridge, N. A. Gillett, and E. P. Amento, "TGF-beta-1 induces bone closure of skull defects," J. Bone Miner. Res., 6, 1257-1265 (1991).
13. L. S. Beck, E. P. Amento, Y. Xu, L. Deguzman, W. P. Lee, T. Nguyen, and N. A. Gillett, "TGF-beta(1) induces bone closure of skull defects - Temporal dynamics of bone formation in defects exposed to rhTGF-beta(1)," J. Bone Miner. Res., 8, 753-761 (1993).
14. R. Derynck, J. A. Jarrett, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel, "Human transforming growth factor-β complementary DNA sequence and expression in nor-mal and transformed cells," Nature, 316, 701-705 (1985).
15. C. A. Frolik, L. M. Wakefield, D. M. Smith, and M. B. Sporn, "Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts," J. Biol. Chem., 259, 10995-11000 (1984).
16. L. Richardson, T. F. Zioncheck, E. P. Amento, L. Deguzman, W. P. Lee, Y. Xu, and L. S. Beck, "Characterization of radioiodinated recombinant human TGF-beta 1 binding to bone matrix within rabbit skull defects," J. Bone Miner. Res., 8, 1407-1414 (1993).
17. D. Danielpour, "Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor-beta1," J. Immunol. Meth., 158, 17-25 (1993).
18. R. F. Tucker, G. D. Shipley, H. L. Moses, and R. W. Holley, "Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor," Science, 226, 705-707 (1984).
19. D. Danielpour, L. L. Dart, K. C. Flanders, A. B. Roberts, and M. B. Sporn, "Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture," J. Cell. Physiol., 138, 79-86 (1989).
20. M. F. Chaplin, "Monosaccharides," in Carbohydrate Analysis, a Practical Approach, M. F. Chaplin and J. F. Kennedy (eds.), IRL Press, Oxford, 1986, p. 3.
21. C. J. Damien and J. R. Parsons, "Bone graft and bone graft substitutes - A review of current technology and applications," J. Appl. Biomater., 2, 187-208 (1991).
22. D. J. Kibblewhite, A. G. Bruce, D. M. Strong, S. M. Ott, A. F. Purchio, and W. F. Larrabee, "Transforming growth factor-beta accelerates osteoinduction in a craniofacial onlay model," Growth Factors, 9, 185-193 (1993).
23. R. A. Kenley, K. Yim, J. Abrams, E. Ron, T. Turek, L. J. Marden, and J. O. Hollinger, "Biotechnology and bone graft substitutes," Pharm. Res., 10, 1393-1401 (1993).
24. T. Kawakami, H. Uji, M. Antoh, H. Hasegawa, T. Kise, and S. Eda, "Squalane as a possible carrier of bone morphogenetic protein," Biomaterials, 14, 575-577 (1993).
25. S. C. Lee, M. Shea, M. A. Battle, K. Kozitza, E. Ron, T. Turek, R. G. Schaub, and W. C. Hayes, "Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PLGA matrix," J. Biomed. Mater. Res., 28, 1149-1156 (1994).
26. W. R. Gombotz, S. C. Pankey, L. S. Bouchard, J. Ranchalis, and P. Puolakkainen, "Controlled release of TGF-beta(1) from a biodegradable matrix for bone regeneration," J. Biomater. Sci. Polym. Edn., 5, 49-63 (1993).
27. W. R. Gombotz, S. C. Pankey, L. S. Bouchard, D. H. Phan, and P. A. Puolakkainen, "Stimulation of bone healing by transforming growth factor-beta1 released from polymeric or ceramic implants," J. Appl. Biomater., 5, 141-150 (1994).
28. D. S. Metsger, A. M. C. Faugere, and H. H. Malluche, "Histomorphometric analysis of tricalcium phosphate ceramic implanted into turkeys," Bone, 14, 243-248 (1993).
29. M. B. Sporn and A. B. Roberts, "The multifunctional nature of peptide growth factors," in Handbook of Experimental Pharmacology: Peptide growth factors and their receptors, M. B. Sporn and A. B. Roberts (eds.), Springer-Verlag, New York, 1990, pp. 3-15.
30. B. Ongpipattanakul, M. Cromwell, R. Wong, and T. Nguyen, "The adsorption of rhTGF-β1 and its release from tricalcium phosphate," Pharm. Res., 11, S82 (1994).
31. L. Vroman and A. L. Adams, "Identification of rapid changes at plasma-solid interfaces," J. Biomed. Mater. Res., 3, 43-67 (1969).
32. R. E. Baier and R. L. Dutton, "Initial events in interactions of blood with foreign surface," J. Biomed. Mater. Res., 3, 191-206 (1969).
33. J. L. Brash and P. ten Hove, "Effect of plasma dilution on adsorption of fibrinogen to solid surfaces," Thromb. Haemostas., 51, 326-330 (1984).